Site-specific integration and tailoring of cassette design for sustainable gene transfer
- PMID: 21857672
- DOI: 10.1038/nmeth.1674
Site-specific integration and tailoring of cassette design for sustainable gene transfer
Abstract
Integrative gene transfer methods are limited by variable transgene expression and by the consequences of random insertional mutagenesis that confound interpretation in gene-function studies and may cause adverse events in gene therapy. Site-specific integration may overcome these hurdles. Toward this goal, we studied the transcriptional and epigenetic impact of different transgene expression cassettes, targeted by engineered zinc-finger nucleases to the CCR5 and AAVS1 genomic loci of human cells. Analyses performed before and after integration defined features of the locus and cassette design that together allow robust transgene expression without detectable transcriptional perturbation of the targeted locus and its flanking genes in many cell types, including primary human lymphocytes. We thus provide a framework for sustainable gene transfer in AAVS1 that can be used for dependable genetic manipulation, neutral marking of the cell and improved safety of therapeutic applications, and demonstrate its feasibility by rapidly generating human lymphocytes and stem cells carrying targeted and benign transgene insertions.
Similar articles
-
Chromatin structure of two genomic sites for targeted transgene integration in induced pluripotent stem cells and hematopoietic stem cells.Gene Ther. 2013 Feb;20(2):201-14. doi: 10.1038/gt.2012.25. Epub 2012 Mar 22. Gene Ther. 2013. PMID: 22436965 Free PMC article.
-
Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.Gene Ther. 2003 Sep;10(19):1691-702. doi: 10.1038/sj.gt.3302061. Gene Ther. 2003. PMID: 12923568
-
Characterization of three loci for homologous gene targeting and transgene expression.Biotechnol Bioeng. 2013 Aug;110(8):2225-35. doi: 10.1002/bit.24892. Epub 2013 May 2. Biotechnol Bioeng. 2013. PMID: 23475535
-
[Integration of AAV vectors and insertional mutagenesis].Med Sci (Paris). 2016 Feb;32(2):167-74. doi: 10.1051/medsci/20163202010. Epub 2016 Mar 2. Med Sci (Paris). 2016. PMID: 26936174 Review. French.
-
Site-specific integration by the adeno-associated virus rep protein.Curr Gene Ther. 2011 Oct;11(5):399-405. doi: 10.2174/156652311797415809. Curr Gene Ther. 2011. PMID: 21827397 Review.
Cited by
-
HIV-1 infection of genetically engineered iPSC-derived central nervous system-engrafted microglia in a humanized mouse model.J Virol. 2023 Dec 21;97(12):e0159523. doi: 10.1128/jvi.01595-23. Epub 2023 Nov 30. J Virol. 2023. PMID: 38032195 Free PMC article.
-
Advances in targeted genome editing.Curr Opin Chem Biol. 2012 Aug;16(3-4):268-77. doi: 10.1016/j.cbpa.2012.06.007. Epub 2012 Jul 20. Curr Opin Chem Biol. 2012. PMID: 22819644 Free PMC article. Review.
-
Recent developments and clinical studies utilizing engineered zinc finger nuclease technology.Cell Mol Life Sci. 2015 Oct;72(20):3819-30. doi: 10.1007/s00018-015-1956-5. Epub 2015 Jun 19. Cell Mol Life Sci. 2015. PMID: 26089249 Free PMC article. Review.
-
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs.Mol Ther. 2023 Jan 4;31(1):230-248. doi: 10.1016/j.ymthe.2022.08.011. Epub 2022 Aug 17. Mol Ther. 2023. PMID: 35982622 Free PMC article.
-
CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications.Pharmaceutics. 2021 Oct 9;13(10):1649. doi: 10.3390/pharmaceutics13101649. Pharmaceutics. 2021. PMID: 34683943 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
